How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Airway Clearance Devices System Market
- By Product Type: Positive Expiratory Pressure (PEP) Devices, Oscillatory Positive Expiratory Pressure (OPEP) Devices, High Frequency Chest Wall Oscillation (HFCWO) Devices, Mechanical Insufflation-Exsufflation (MIE) Devices, Intrapulmonary Percussive Ventilation (IPV) Devices
- By End User: Hospitals, Home Care Settings, Specialty Clinics, Rehabilitation Centers, Long-term Care Facilities
- By Indication: Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, Neuromuscular Disorders, Postoperative Respiratory Care
- By Technology: Manual Airway Clearance Devices, Mechanical Airway Clearance Devices, Electronic Airway Clearance Devices
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Positive Expiratory Pressure (PEP) Devices leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.167 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.175 →
Full report · locked preview
Everything inside the Airway Clearance Devices System Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
End User 5
Indication 5
Technology 3
Companies profiled
Philips Respironics
Hill-Rom Holdings (a Baxter International company)
Smiths Medical (a division of ICU Medical)
Medtronic
ResMed
Becton Dickinson and Company (BD)
Teleflex Incorporated
Vyaire Medical
Pari Respiratory Equipment Inc.
Intersurgical Ltd.
Fisher & Paykel Healthcare
DeVilbiss Healthcare (a division of Drive DeVilbiss Healthcare)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Philips Respironics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Hill-Rom Holdings (a Baxter International company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Smiths Medical (a division of ICU Medical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →ResMed
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Teleflex Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Vyaire Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Pari Respiratory Equipment Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Intersurgical Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Fisher & Paykel Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →DeVilbiss Healthcare (a division of Drive DeVilbiss Healthcare)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →AstraZeneca (via Pulmonx acquisition)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Pulmonx Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Somnetics International
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,920M by 2033 · 6.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Positive Expiratory Pressure (PEP) Devices56.2
- Oscillatory Positive Expiratory Pressure (OPEP) Devices8.2
- High Frequency Chest Wall Oscillation (HFCWO) Devices14.9
- Mechanical Insufflation-Exsufflation (MIE) Devices11.1
- Intrapulmonary Percussive Ventilation (IPV) Devices9.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$978.8M → $1,684M · 7.0%
Europe$682.2M → $1,012M · 5.1%
Asia Pacific$622.9M → $976.8M · 5.8%
Latin America$385.6M → $709.5M · 7.9%
Middle East and Africa$296.6M → $493.7M · 6.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.492026
6.482027
6.512028
6.512029
6.532030
6.552031
6.562032
6.562033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Philips Respironics21.1
- Hill-Rom Holdings (a Baxter International company)16.8
- Smiths Medical (a division of ICU Medical)4.2
- Medtronic11.9
- ResMed10.3
- Becton Dickinson and Company (BD)7.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type33.6%
End User21.5%
Indication22.8%
Technology22.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.5
- Europe20.8
- Asia Pacific20.0
- Latin America14.5
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Philips Respironics | 94 | 87 | 74 | 82 | 76 | 93 | 84 |
| Hill-Rom Holdings (a Baxter International company) | 72 | 86 | 71 | 70 | 92 | 91 | 80 |
| Smiths Medical (a division of ICU Medical) | 80 | 72 | 65 | 85 | 74 | 84 | 77 |
| Medtronic | 57 | 65 | 79 | 67 | 63 | 73 | 67 |
| ResMed | 66 | 53 | 71 | 67 | 55 | 66 | 63 |
| Becton Dickinson and Company (BD) | 50 | 48 | 65 | 65 | 54 | 47 | 55 |
| Teleflex Incorporated | 48 | 40 | 50 | 40 | 53 | 59 | 48 |
| Vyaire Medical | 56 | 54 | 45 | 38 | 43 | 60 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Philips Respironics
- Hill-Rom Holdings (a Baxter International company)
- Smiths Medical (a division of ICU Medical)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Philips Respironics | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Hill-Rom Holdings (a Baxter International company) | − | ✓ | ✓ | − | ✓ | ✓ |
| Smiths Medical (a division of ICU Medical) | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Medtronic | − | ✓ | ✓ | − | ◐ | ◐ |
| ResMed | ◐ | ◐ | ◐ | − | − | ◐ |
| Becton Dickinson and Company (BD) | − | − | ◐ | − | ◐ | ◐ |
| Teleflex Incorporated | ◐ | − | ◐ | − | − | ◐ |
| Vyaire Medical | ◐ | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Philips Respironics84
2Hill-Rom Holdings (a Baxter International company)80
3Smiths Medical (a division of ICU Medical)77
4Medtronic67
5ResMed63
6Becton Dickinson and Company (BD)55
7Vyaire Medical49
8Teleflex Incorporated48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Philips RespironicsHill-Rom Holdings (a Baxter International company)
Challenger2
Strong scale, closing on the leaders.
Smiths Medical (a division of ICU Medical)Medtronic
Contender1
Focused players with pockets of strength.
ResMed
Niche3
Specialists in a single segment or region.
Becton Dickinson and Company (BD)Teleflex IncorporatedVyaire Medical
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Airway Clearance Devices System Market — a $365M beachhead inside a $7.24B market.
Beachhead (SOM)$365Mobtainable near-term
Serviceable (SAM)$2.50Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Positive Expiratory Pressure (PEP) Devices
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Oscillatory Positive Expiratory Pressure (OPEP) Devices
Strong fit — clear ROI and a fast path to value.
End user68 fit
High Frequency Chest Wall Oscillation (HFCWO) Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Indication
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve23%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Airway Clearance Devices System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified25%
Evaluation11%
Closed-won5%
$14.2KCAC
$65KLTV
4.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Airway Clearance Devices System Market is a resilient opportunity — $3.73B by 2033, compounding at 4.7%.
TAM · 2025$2.58Btoday
TAM · 2033$3.73Bforecast
CAGR4.7%2027–2033
Cumulative$28.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.73BTotal addressable market
SAM$1.39BServiceable available market
SOM$236MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.7% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.73BLarge & growingTAM by 2033 at 4.7% CAGR
$1.39BServiceable nowreachable with today’s model
$236MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.91BBear3.1% CAGR
$3.73BBase4.7% CAGR
$4.77BBull6.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Airway Clearance Devices System Market — a $3.70B market by 2033. Plan: grow share from 8.7% to 17.1%.
Market size · 2033$3.70Btotal addressable
Market CAGR3.3%2027–2033
Target share17.1%from 8.7% today
Revenue ambition$633Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.7% | 17.1% | Behind |
| Revenue | $294M | $633M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 29.1% | 39.3% | On track |
| Customer retention | 87.1% | 95.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $94M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Airway Clearance Devices System Market conversation — a $583M market you can size, segment and defend in minutes.
Market size · 2033$583Mtotal opportunity
Growth3.8%CAGR to 2033
Addressable buyers1,131+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 3 mopayback period
$100K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Philips RespironicsHill-Rom Holdings (a Baxter International company)Smiths Medical (a division of ICU Medical)MedtronicResMedBecton Dickinson and Company (BD)Teleflex IncorporatedVyaire Medical+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Airway Clearance Devices System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Airway Clearance Devices System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Neuromuscular Blocking Agent (NMBA) Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportAirway Clearance Devices for Cystic Fibrosis Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportDiphtheria Vaccines Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportAirway Catheter Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportAirway and Respiratory Device Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportFunctional Sugar for Pharmaceutical Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportAirway Adapters Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportAir Wave Pressure Therapy System Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportHyaluronidase Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportAir Wave Pressure Therapy Device Market
Market size, share, segmentation and regional forecast.
$320M market · 2025 base year
View reportHemocoagulase Atrox Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportAir Wave Pressure Therapy Apparatus Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.